Adult Polyglucosan Body Disease (APBD) is a rare genetic disorder characterized by the accumulation of abnormal glycogen deposits in nerve cells. The ICD10 code for APBD is G71.09, which falls under the category of "Other specified myopathies." Unfortunately, there is no specific ICD9 code for APBD as it was replaced by ICD10 codes in 2015.
Adult Polyglucosan Body Disease (APBD) is a rare neurological disorder characterized by the accumulation of polyglucosan bodies in various tissues, particularly in the nervous system. These bodies are abnormal accumulations of glycogen, a complex sugar molecule. APBD is typically diagnosed in adulthood and is caused by mutations in the GBE1 gene, which is responsible for producing an enzyme called glycogen branching enzyme.
In terms of coding, APBD does not have a specific ICD10 code. However, it may be classified under the broader category of "Other specified degenerative diseases of the nervous system" (ICD10 code: G31.8). This category includes rare neurodegenerative disorders that do not have their own specific codes. It is important to note that the specific diagnosis should be confirmed by a healthcare professional to ensure accurate coding.
In the previous ICD9 coding system, APBD also did not have a specific code. It would have been classified under the category "Other specified degenerative diseases of the nervous system" (ICD9 code: 331.89), similar to the ICD10 classification.
It is crucial to consult with a healthcare professional or utilize specific coding guidelines to ensure accurate coding and documentation for APBD, as the ICD coding systems are regularly updated to reflect advances in medical knowledge and terminology.